Management Team


Co-founder, Chief Executive Officer & Director

With more than thirty years of executive, general management, business development, sales, marketing, and technology commercialization experience, Mr. Sharp’s career spans private venture-backed businesses, mid-size and Fortune 100 public companies in the medical device, diagnostics and life science tools and services markets. Mr. Sharp has served in senior leadership roles with five venture-backed companies—as Chief Executive Officer of CYTOO, Inc. and ArunA Biomedical, Chief Commercial Officer of BioProcessors Corporation (acquired by Seahorse Biosciences), SVP Business Development of Cellomics (acquired by Fisher International), and VP Business Development of Gentra Systems (acquired by Qiagen). Earlier career includes senior leadership roles with Life Technologies, General Manager of Terumo Medical, Vice President of Sales and Marketing at Heraeus Instruments and roles of increasing responsibility within the diagnostics business of Baxter Healthcare and a medical device subsidiary of Eli Lilly. Mr. Sharp has successfully commercialized more than 500 products and services. Earned M.S. and B.A. degrees from the Pennsylvania State University.


Chief Operating Officer

Bringing over thirty years of experience in the pharmaceutical, biomedical and biotechnology industries to ZyMot Fertility, Mr. Sly has global responsibility for marketing, regulatory, manufacturing and overall business operations. Prior to joining the team, Mr. Sly directed the commercial strategy, marketing and business development activities for Baltimore-based Paragon Bioservices. Throughout his career, Mr. Sly’s focus has primarily been strategic marketing and business development, from leading the efforts in pharmaceutical technology licensing and product development (including Phase I–III development and commercial manufacturing), to the development of business strategy and strategic commercial development for a range of biopharmaceutical products. Mr. Sly joined the Maryland business community in 2002 as Chief Business Officer for a private start-up, Advancis Pharmaceutical Corporation, playing a critical role in establishing a strong marketing presence, delivering key validating licensing and acquisition deals, serving on the core IPO deal team and leading the post-IPO efforts to establish the company’s first commercial operations. He received his B.A. in Biology (pre-med) from Pomona College.


EVP and Chief Financial Officer

Mr. Shippy has more than 25 years of experience advising MedTech, diversified healthcare, and other companies. He has served in a strategic finance role for companies at all stages of their lifecycles, from start-up to exit, including on an interim CFO basis. Mr. Shippy’s background includes not only public accounting and corporate finance, but also strategy consulting and investment banking. Mr. Shippy is the Founder and CEO of Audacity Investment Bankers, a boutique investment bank and management consulting firm that is dedicated to serving MedTech companies of all types, including FDA-approved medical device companies and contract manufacturers. Prior to founding Audacity, Mr. Shippy was a Partner and Director of Healthcare at Stout Investment Bank, one of the nation’s fastest growing middle-market investment banks. Prior to Stout, he served as an investment banker at Houlihan Lokey, one of the nation’s largest Wall Street investment banks. Prior to investment banking, he was a strategy consultant at Accenture. Mr. Shippy also worked at Epic Ventures, a former Draper Fisher Jurvetson affiliate and early-stage venture capital firm with a focus on investing in early-stage biotech and other disruptive technology ventures. He began his career as a licensed CPA at a major global public accounting firm. Mr. Shippy holds an M.B.A. in International Finance from Thunderbird, and a B.S. in Accountancy from Northern Illinois University.


EVP and General Counsel

Mr. Goroff brings over thirty years of diverse experience as a corporate lawyer, entrepreneur, and advisor to business and non-profit enterprises. He began his legal career at Wachtell Lipton Rosen & Katz, and from 1992-2007 was a partner at Milbank Tweed Hadley & McCloy in New York and London, where he focused on public and private M&A and financially complex private equity transactions. Since 2007, Mr. Goroff has engaged in a mix of business and mission-driven activities. He has been involved in several early-stage, impact-oriented enterprises as a founder, investor, advisor, or lawyer, and spent three years as a Senior Managing Director at Avenue Capital in a non-legal role on two SPAC transactions. Mr. Goroff has, in parallel, devoted substantial time to global health, international development, and anti-poverty matters. He holds a graduate degree in global public health and has served as a consultant to related public and private entities and projects. He has had roles in mission-driven enterprises, including governance roles in a highly prominent international NGO, and directs mission-driven venture investing for a substantial family foundation. Michael earned an AB from Harvard College and JD from Harvard Law School. In mid-career, he received an MPH from the Harvard School of Public Health, where he was subsequently a Takemi Fellow in International Health.


Vice President of Sales, Human Fertility Market

Mr. Giannetti is an accomplished sales leader with over twelve years of demonstrated success in the medical industry. He has worked side-by-side with hundreds of medical professional to help improve patient care by introducing new and efficacious treatment modalities. Mr. Giannetti has also supported the growth of his partners’ medical clinics by creating patient retention programs, executing marketing initiatives to attract new patients, as well as the implementation of new revenue streams. With experience ranging across multiple medical disciplines, in both large companies as well as multiple start-ups, Mr. Giannetti brings a broad scope of insight to the ZyMōt Fertility team. His passion for improving patient outcomes and being a true partner to our customers has been a welcomed addition since joining the team in January 2020. Mr. Giannetti earned his B.S. from Montclair State University.


Vice President of Sales, Veterinary Fertility Market

Mr. Rau’s career extends over three decades in sales, sales management, business development, basic research and product development. His responsibilities for DxNow are currently focused on developing our global business efforts in veterinary fertility and our human fertility distribution network in the Asia-Pacific region. Mr. Rau’s experience spans venture-backed businesses, mid-size and Fortune 500 public companies in the medical device, diagnostics and life science tools and services markets. Mr. Rau’s venture-backed experience includes his most recent role as Director of Business Development for Spartan Bioscience in which he successfully established global distribution channels plus engaged in the initiation and direction of collaborative partnerships. Previous business development, sales, and sales management experience includes fourteen years with Gentra Systems (acquired by Qiagen) where he held all sales records, Sequenom, and Pall Corporation. During his early career, Mr. Rau gained basic research and product development experience at Kallestad (now owned by Danaher – Beckman Coulter), the University of Wisconsin and the University of Minnesota. Mr. Rau earned his B.S. degree from the University of Wisconsin-Madison.


International Sales Director

Mr. Leer brings over twenty years of experience in reproductive medicine and women’s health to ZyMōt Fertility. Having established and managed sales distribution partnership networks in more than 65 countries throughout his career, as well as having developed and launched innovative products to the fertility market, Mr. Leer brings important depth and on-the-ground experience to the team as we continue our efforts to drive market penetration globally. Based out of the United Kingdom, Mr. Leer has held senior business development and sales management positions with market leading companies, such as Merck Serono, Cooper Origio and Igenomix. His earlier experiences involved establishing and managing sales, marketing and distribution capabilities for medical device products throughout Europe, Asia, the Middle East, the United States, and South America. Mr. Leer received his formal qualifications in Business and Finance from Portsmouth College in the UK.

Allan Caban

Director, Product Development and Manufacturing

Mr. Caban is a highly accomplished engineer with over 20 years of experience in the medical device industry. He specializes in developing, launching, and manufacturing innovative medical devices. Mr. Caban has the unique experience of having been directly responsible for taking designs from a pencil sketch through development and into high-volume manufacturing. He has worked for both large corporations (Texas Instruments, Motorola, Harris Corporation) as well as multiple early-stage companies. Mr. Caban is named on several issued patents, led the mechanical design of the world’s smallest glucose meter, named Sidekick, and was a key contributor to the successful launch and regulatory approval of the first long-term implantable glucose sensor, Eversense. He has also been responsible for the design and successful qualification of fully automated production and packaging lines. He earned a B.S. degree in Mechanical Engineering from the University of Florida and is a certified Lean Six Sigma Black Belt.